Matthew Miner
Associate
Washington, D.C.

Matthew Miner
Associate
Washington, D.C.
Contact details
Dr. Miner is an associate in the Intellectual Property practice in the Washington, D.C. office. Dr. Miner’s practice focuses on patent litigation, patent opinions, and due diligence projects in the life sciences space. Dr. Miner has experience working on matters involving small molecule and biologic pharmaceuticals, polymorphs, industrial polymers, and various medical devices.
While attending law school, Dr. Miner was a scientific advisor at another global law firm where he leveraged his scientific background to assist with patent litigations, patentability opinions, and freedom-to-operate analyses. Prior to law school, Dr. Miner earned a Ph.D. in Organic Chemistry from New York University where he studied the development of new methods for the synthesis of biologically active hydroperoxides and endocyclic peroxides. Dr. Miner also performed research in the field of supramolecular chemistry, exploring the host-guest relationships between synthetic lectins and various saccharides. As a result of his graduate work, Dr. Miner is well-versed in a number of analytical techniques used in the pharmaceutical industry.
Dr. Miner has published a number of scientific articles and has presented his research at regional and national scientific meetings and conferences. He is also a co-inventor of one U.S. patent.
Qualifications
Professional
Admitted: District of Columbia Bar, 2023
Admitted: Bar of the State of New York, 2022
Not admitted in Massachusetts/Supervised by the Principals of the Firm
Academic
JD, Suffolk University School of Law, 2021
Ph.D., Organic Chemistry, New York University, 2016
B.S., Chemistry, State University of New York at Oneonta, 2009
Related articles

Publications: 27 April 2022
Webinar: Orange Book listing sheets under the microscope
Preparing the Orange Book listing sheet (i.e., Form FDA 3542) for a U.S. patent is more than just checking the boxes.

Qualifications
Professional
Admitted: District of Columbia Bar, 2023
Admitted: Bar of the State of New York, 2022
Not admitted in Massachusetts/Supervised by the Principals of the Firm
Academic
JD, Suffolk University School of Law, 2021
Ph.D., Organic Chemistry, New York University, 2016
B.S., Chemistry, State University of New York at Oneonta, 2009
Published work
- Co-author, (2021) “Medicinal Chemist’s Guide to Patents: Key Concepts and Strategies,” Presented at the Spring 2021 National Meeting of the American Chemical Society, April 5–16, Division of Medicinal Chemistry, Paper No. 3552076
- Lead Author, (2016) “CuI -Catalyzed Synthesis of Propargyl Hydroperoxides Using Molecular Oxygen and Hydroxylamines,” EUROPEAN J. ORG. CHEM., 10, p.1860-66
- Co-author, (2015) “Copper(I)-Catalyzed Oxidation of Alkenes Using Molecular Oxygen and Hydroxylamines: Synthesis and Reactivity of α-Oxygenated Ketones,” ORG. LETT., 11, p.2704-07
- Co-author, (2015) “Formation of an Endoperoxide upon Chromium-Catalyzed Allylic Oxidation of a Triterpene by Oxygen,” J. ORG. CHEM., 1, p.266-73
- Co-author, (2014) “Synthesis of Silyl Monoperoxyketals by Regioselective Cobalt-Catalyzed Peroxidation of Silyl Enol Ethers: Application to the Synthesis of 1,2-Dioxolanes,” ORG. LETT., 16, p.4280-83
- Co-author, (2012) “Saccharide Receptor Achieves Concentration Dependent Mannoside Selectivity Through Two Distinct Cooperative Binding Pathways,” CHEM. SCI., 4, p.357-67
- Co-author, (2009) “Ethyl Lactate as a Tunable Solvent For The Synthesis of Aryl Aldimines,” GREEN CHEM., 11, p.166-68
- Co-inventor, U.S. Patent No. 9,296,688 “Carbohydrate Selective Receptors”